Cargando…
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin αIIbβ3
Integrin αIIbβ3 plays a crucial role in the process of platelet aggregation. Three integrin αIIbβ3 antagonists (abciximab, eptifibatide, and tirofiban) have been approved by FDA for clinical use. Unfortunately, they all showed severe side effects such as thrombocytopenia and bleeding risk. Thus, res...
Autores principales: | Ding, Xue, Liu, Tong-dan, Xie, Zhou-ling, Zhao, Qi, Cao, Yuan, Liu, Xiao-dong, Wang, Cai-hui, Gamariel, Rwibasira Rudinga, Ming, Xin, Li, Zhi-yu, Kong, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206433/ https://www.ncbi.nlm.nih.gov/pubmed/28097150 http://dx.doi.org/10.1155/2016/8587164 |
Ejemplares similares
-
Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
por: Rwibasira Rudinga, Gamariel, et al.
Publicado: (2018) -
Pregnancy-Specific Glycoproteins Bind Integrin αIIbβ3 and Inhibit the Platelet—Fibrinogen Interaction
por: Shanley, Daniel K., et al.
Publicado: (2013) -
Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability
por: Zou, Jinmi, et al.
Publicado: (2022) -
A Short Half-Life α(IIb)β(3) Antagonist ANTP266 Reduces Thrombus Formation
por: Liu, Tong-Dan, et al.
Publicado: (2018) -
Inhibition of platelet adhesion, thrombus formation, and fibrin formation by a potent αIIbβ3 integrin inhibitor from ticks
por: van den Kerkhof, Danique L., et al.
Publicado: (2020)